Reported May 31, 2023 · Terminated
buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun…
Sun Pharmaceutical Industries Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: SUN PHARMACEUTICAL INDUSTRIES INC · 2 Independence Way · Princeton, NJ · 08540-6620
Is this the product you have?
- buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only
- Distributed bySun Pharmaceutical Industries, Inc., Cranbury, NJ
- Manufactured bySun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86
- Lot codes and dates
- Lots
HAC2240AExp 05/2023HAC3162AExp 07/2023
- Lots
- Amount recalled
- 5,344 Bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications; during stability testing
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Sun Pharmaceutical Industries Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.